e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Respiratory problems and new ways of evaluating the patient with cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients
R. M. Effros, J. Biller, F. Sun, B. Foss (Milwaukee, United States Of America)
Source:
Annual Congress 2002 - Respiratory problems and new ways of evaluating the patient with cystic fibrosis
Session:
Respiratory problems and new ways of evaluating the patient with cystic fibrosis
Session type:
Thematic Poster Session
Number:
3281
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. M. Effros, J. Biller, F. Sun, B. Foss (Milwaukee, United States Of America). Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients. Eur Respir J 2002; 20: Suppl. 38, 3281
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Serum lipid concentrations and malnutrition in adult cystic fibrosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 58s
Year: 2006
KL-6 serum levels in adult cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001
Glucose tolerance during pulmonary exacerbations in children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Plasma leakage is elevated in COPD airways
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Detection of elevated 2-propanol in breath samples from children with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018
Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with
pseudomonas aeruginosa
colonisation
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Changes in lung gas mixing after physiotherapy in adults with cystic fibrosis
Source: Annual Congress 2007 - Critical care and airways clearance
Year: 2007
Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH
Source: Eur Respir J, 52 (6) 1801297; 10.1183/13993003.01297-2018
Year: 2018
Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function
Source: Eur Respir J 2014; 44: 1253-1261
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept